Clinical trial · Observational
Exploring Accessible Beauty for Individuals With Upper Extremity Deficits
Exploring Accessible Beauty: A Study on Enhancing Beauty Product Accessibility for Individuals With Upper Extremity Deficits
NCT05945784CI-TRIAL-00072028completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to investigate the accessibility of beauty products for individuals with upper extremity disabilities. By examining various factors such as packaging design, product applicators, and ease of use, this research aims to identify barriers faced by individuals with upper extremity disabilities or visual deficits when using beauty products. The study seeks to provide insights and recommendations for improving the accessibility of beauty products, ultimately promoting inclusivity and enhancing the overall beauty experience for individuals with disabilities.
Conditions
Conditions (14)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Amyotrophic Lateral Sclerosis | — | UNRESOLVED | — |
| Ehlers-Danlos Syndromes (EDS) | — | UNRESOLVED | — |
| Graves Disease | — | UNRESOLVED | — |
| Guillain-Barre Syndrome | — | UNRESOLVED | — |
| Lupus Erythematosus | — | UNRESOLVED | — |
| Multiple Sclerosis | — | UNRESOLVED | — |
| Muscular Dystrophies | — | UNRESOLVED | — |
| Myasthenia Gravis | — | UNRESOLVED | — |
| SCI - Spinal Cord Injury | — | UNRESOLVED | — |
| Stroke, Acute | — | UNRESOLVED | — |
| Stroke (CVA) or TIA | — | UNRESOLVED |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Use of Rare Beauty makeup products | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Minimal to moderate upper extremity deficits
- description
- * Individuals aged 18 years to 55 years. * Minimal to moderate upper extremity deficits, including but not limited to limited mobility or dexterity impairments. * Regular users of beauty products. * Able to understand and communicate in the language of the study.
- interventionNames
- Other: Use of Rare Beauty makeup products
Primary outcomes (6)
- measure
- Likert Scale
- timeFrame
- Complete on Day 7
- description
- It is a validated self-reported instrument to assess packaging of the makeup. A few questions will focus on shape of the cap, length of the wand, shape of the doe foot, finish of the components, how it affects grip, and weight of the component/applicator. Possible scores range from 1 (strongly disagree) to 5 (strongly agree).
- measure
- Likert Scale
- timeFrame
- Complete on Day 14
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 55 Years
Show eligibility criteria text
Inclusion Criteria: Individuals aged 18 years to 55 years. * Minimal to moderate upper extremity deficits, including but not limited to limited mobility or dexterity impairments. * Regular users beauty products. * Able to understand and communicate in the language of the study. Exclusion Criteria: * Individuals below 18 years of age or over the age of 55. * Individuals without upper extremity deficits or with severe upper extremity deficits that may affect the participant's ability to engage in study activities. * Participants who are not regular users of beauty products. * Inability to understand and communicate in the language of the study. * Any medical or psychological condition that may affect the participant's ability to provide informed consent or engage in the study activities safely. * Individuals who experience facial skin or eye irritation reported by subject or observed by evaluator at baseline visit * History of allergic reactions, and/or known allergies to cosmetic ingredients, toiletries, sunscreens, etc. * Immunocompromised subjects * Individuals who may experience changes in hormones, such as just those using oral contraception for less than three months before the screening visit or who have changed hormonal contraceptive methods within the three months before the Baseline visit or planning to modify hormonal contraception treatment within the duration of the study. * Known to be pregnant, lactating or planning to become pregnant within six months. Subjects who become pregnant during the study must inform the Principal Investigator immediately.
References
Publications (3)
- BACKGROUNDSkelton H, Gill S, Al Zidjaly N, et al. Exploring the Accessibility of Beauty Products for Individuals with Mobility Disabilities. J Appl Cosmetol. 2020;38(3):65-72.
- BACKGROUNDSmith A, Johnson R, Thompson A, et al. Enhancing Accessibility: Designing Inclusive Beauty Products for All Abilities. J Inclusive Design. 2021;1(2):89-102
- BACKGROUNDChen L, Kim D, Park J, et al. A Review on Product Accessibility Evaluation Methods for People with Disabilities. Int J Ind Ergon. 2019;71:103-117. doi:10.1016/j.ergon.2018.11.007